Delivery Order SPE2DB22D1106-SPE2DB25FEPM3
Award Date
5/21/25
Potential Completion Date
6/12/25
Potential Value
$51K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML medical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $27,926.40 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 24, 2025. There is no set-aside designation for this...
This federal contract award is for the delivery of GAMUNEX-C 20 gram/200 ml vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,377.17 and an ultimate completion date of March 28, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 gram/400 ml vials, a medication used for immunotherapy treatments. The contract is a firm fixed-price delivery order with a ceiling value of $55,852.80 and a performance period ending on May 22, 2025. The contract is not set aside for any specific business type....
This contract award is for the delivery of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,394.46 and an ultimate completion date of December 30, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The $12,324.10 firm-fixed-price delivery order is for GAMUNEX-C 20 gram/200 ml vials, a specialty pharmaceutical product, with a completion date of December 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $4,720.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 20 gram/200 ml vials, a medical product, and has an ultimate completion date of January 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside. AmerisourceBergen also holds a...
This federal contract award is for the delivery of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $24,876.40 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 6, 2024, with a performance period ending on December 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of GAMUNEX-C 20 gram/200 mL vials to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $7,147.50 and a completion date of July 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
The federal contract award is for the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) on March 10, 2025. The firm-fixed-price delivery order has a ceiling value of $28,323.36 and a completion date of March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract valued at $28,854.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution services company. The delivery order is for the product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML and has a period of performance through April 1, 2024. This award is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...